CIK: 0001822947
Total reported value
$123.8M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SLNOEUR | Soleno Therapeutics INC | Stock-Other | 22.74% | +2.72% | +208.96% | |
| 2 | REPL | Replimune Group INC | Stock-Other | 9.19% | -10.62% | +581.18% | |
| 3 | MDGL | Madrigal Pharmaceuticals INC | Stock-Healthcare | 9.12% | — | — | |
| 4 | CMPS | Compass Pathways PLC | Stock-Other | 7.58% | -3.24% | +46.27% | |
| 5 | ATAI | AtaiBeckley Inc. | Stock-Other | 7.37% | -7.30% | EXIT | |
| 6 | ASND | Ascendis Pharma A/S | Stock-Other | 6.18% | — | — | |
| 7 | LENZ | Lenz Therapeutics INC | Stock-Other | 4.97% | — | -48.92% | |
| 8 | TSHA | Taysha Gene Therapies INC | Stock-Other | 3.78% | -5.48% | EXIT | |
| 9 | AMLX | Amylyx Pharmaceuticals INC | Stock-Other | 3.62% | — | — | |
| 10 | EPRX | Eupraxia Pharmaceuticals INC | Stock-Other | 3.29% | +0.73% | — | |
| 11 | PRAX | Praxis Precision Medicines I | Stock-Other | 3.23% | +2.44% | +23.64% | |
| 12 | MNPR | Monopar Therapeutics INC | Stock-Other | 3.21% | — | +86.63% | |
| 13 | ARQT | Arcutis Biotherapeutics INC | Stock-Other | 2.68% | — | — | |
| 14 | BRD1EUR | Mind Medicine Mindmed INC | Stock-Other | 2.60% | — | -50.23% | |
| 15 | TARS | Tarsus Pharmaceuticals INC | Stock-Other | 2.56% | +4.58% | NEW | |
| 16 | SLDB | Solid Biosciences INC | Stock-Other | 2.06% | +2.03% | -24.15% | |
| 17 | PMNEUR | Promis Neurosciences INC | Stock-Other | 1.61% | — | +367.13% | |
| 18 | AVTX | Avalo Therapeutics INC | Stock-Other | 1.38% | — | — | |
| 19 | TECX | Tectonic Therapeutic INC | Stock-Other | 1.32% | — | -15.33% | |
| 20 | WHWK | Whitehawk Therapeutics INC | Stock-Other | 0.95% | +0.22% | — | |
| 21 | MLTX | Moonlake Immunotherapeutics | Stock-Other | 0.30% | — | — | |
| 22 | ATYR | Atyr Pharma INC | Stock-Other | 0.26% | — | +108.54% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | SLNOEUR | Soleno Therapeutics INC | +15% | +208.96% | Add |
| 2 | PMNEUR | Promis Neurosciences INC | +0.7% | +367.13% | Add |
| 3 | BRD1EUR | Mind Medicine Mindmed INC | +0.5% | -50.23% | Trim |
| 4 | PRAX | Praxis Precision Medicines I | 0% | +23.64% | Add |
| 5 | WHWK | Whitehawk Therapeutics INC | -0.4% | — | Unchanged |
| 6 | TECX | Tectonic Therapeutic INC | -0.8% | -15.33% | Add |
| 7 | ATYR | Atyr Pharma INC | -1.9% | +108.54% | Trim |
| 8 | TARS | Tarsus Pharmaceuticals INC | -3.4% | -41.59% | Trim |
| 9 | REPL | Replimune Group INC | — | NEW | New buy |
| 10 | MDGL | Madrigal Pharmaceuticals INC | — | NEW | New buy |
| 11 | CMPS | Compass Pathways PLC | — | NEW | New buy |
| 12 | SWTXUSD | Springworks Therapeutics INC | — | EXIT | Sold out |
| 13 | ATAI | AtaiBeckley Inc. | — | NEW | New buy |
| 14 | ASND | Ascendis Pharma A/S | — | NEW | New buy |
| 15 | VRNA | Verona Pharma PLC - Adr | — | EXIT | Sold out |
| 16 | AXSM | Axsome Therapeutics INC | — | EXIT | Sold out |
| 17 | LENZ | Lenz Therapeutics INC | — | NEW | New buy |
| 18 | 2655787D | Blueprint Medicines CORP | — | EXIT | Sold out |
| 19 | INSM | Insmed INC | — | EXIT | Sold out |
| 20 | TSHA | Taysha Gene Therapies INC | — | NEW | New buy |
| 21 | AMLX | Amylyx Pharmaceuticals INC | — | NEW | New buy |
| 22 | ✓ | Axsome Therapeutics INC | — | EXIT | Sold out |
| 23 | EPRX | Eupraxia Pharmaceuticals INC | — | NEW | New buy |
| 24 | MNPR | Monopar Therapeutics INC | — | NEW | New buy |
| 25 | ARQT | Arcutis Biotherapeutics INC | — | NEW | New buy |
| 26 | TRVI | Trevi Therapeutics INC | — | EXIT | Sold out |
| 27 | 260 | Centessa Pharmaceuticals-adr | — | EXIT | Sold out |
| 28 | SLDB | Solid Biosciences INC | — | NEW | New buy |
| 29 | ELVN | Enliven Therapeutics INC | — | EXIT | Sold out |
| 30 | ✓ | Merus N V | — | EXIT | Sold out |
| 31 | GERN | Geron CORP | — | EXIT | Sold out |
| 32 | CGON | Cg Oncology INC | — | EXIT | Sold out |
| 33 | XENE | Xenon Pharmaceuticals INC | — | EXIT | Sold out |
| 34 | AVTX | Avalo Therapeutics INC | — | NEW | New buy |
| 35 | EWTX | Edgewise Therapeutics INC | — | EXIT | Sold out |
| 36 | ✓ | Edgewise Therapeutics INC | — | EXIT | Sold out |
| 37 | JANX | Janux Therapeutics INC | — | EXIT | Sold out |
| 38 | DNTH | Dianthus Therapeutics INC | — | EXIT | Sold out |
| 39 | KRRO | Korro Bio INC | — | EXIT | Sold out |
| 40 | TYRA | Tyra Biosciences INC | — | EXIT | Sold out |
| 41 | CNTX | Context Therapeutics INC | — | EXIT | Sold out |
| 42 | MLTX | Moonlake Immunotherapeutics | — | NEW | New buy |